Royal Society of Chemistry, RSC Advances, 33(9), p. 19065-19074, 2019
DOI: 10.1039/c9ra03151k
Full text: Download
A series of 4-(1H-1,2,4-triazol-1-yl)benzoic acid hybrids (1–17) was successfully synthesized and their structures were established by NMR and MS analysis. Their anticancer activity against HCT-116, MCF-7 and normal human RPE-1 cells were examined.